Cannabis Use With GLP-1 Therapy: What a Diabetes Cohort Found
Cannabis and GLP-1 therapy were examined in a matched cohort of 8,234 adults with type 2 diabetes. Cannabis-related diagnosis codes were associated with higher mortality, cardiovascular events, and kidney events. The retrospective design raises a safety…
Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Diabetes
The REALISED study shows significant improvements in HbA1c and body weight among Thai patients using oral semaglutide. No severe hypoglycaemia was reported.
Cancer Incidence Among Users of Glucagon‑Like Peptide‑1 Receptor Agonists
A study involving over 106,000 patients found that GLP-1RA use was associated with a significantly lower risk of liver and pancreatic cancer compared to insulin.
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality
GLP-1 receptor agonists are associated with a statistically significant reduction in all-cause mortality for cancer patients with type 2 diabetes. This study highlights the potential benefits of GLP-1RAs in oncology settings.
GLP‑1 Receptor Agonist Treatment and Health Outcomes in Methadone‑Treated Patien
GLP-1 receptor agonists significantly reduced myocardial infarctions, opioid overdoses, and suicidal ideation in methadone-treated OUD patients with T2D.
Semaglutide vs Tirzepatide: Clinical Evidence & Outcomes
This article reviews dual receptor agonist weight loss effects comparing semaglutide and tirzepatide. Both drugs offer significant glycemic control and metabolic benefits. Understanding their clinical outcomes helps optimize obesity treatment.
Comparing Retatrutide and Mounjaro for Weight Loss Injections
Retatrutide weight loss injections represent a novel triple receptor agonist therapy showing superior efficacy compared to Mounjaro. These GLP-1 receptor agonists offer promising metabolic benefits for adults with obesity. Understanding their differences…
GLP-1 Diabetes Cardiovascular Outcomes: Keto Diet Study Insights
Ketogenic diet intervention offers potential benefits in managing type 2 diabetes alongside GLP-1 therapy. This approach may enhance glycemic control and cardiovascular outcomes. Patients should consult clinicians for personalized guidance on combining…
Mounjaro Counterfeit Seizure: GLP-1 Clinical Supply Chain Risks
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic NewsSupply Chain InvestigationType 2 DiabetesTirzepatideRegulatory AffairsGlobal Patient PopulationDrug…
GLP-1 Receptor Agonists: Clinical Evidence and Facts
GLP-1 receptor agonists clinical evidence and facts highlight their role in glycemic control and weight management. Semaglutide and related drugs show benefits in type 2 diabetes. Understanding safety and patient monitoring is essential for effective…